Nuclear medicine vendor Sopha Medical showed its hand in expandingthe functionality of its line of gamma cameras at this month'smeeting of the Radiological Society of North America. Sopha, ofColumbia, MD, displayed works-in-progress developments in
Nuclear medicine vendor Sopha Medical showed its hand in expandingthe functionality of its line of gamma cameras at this month'smeeting of the Radiological Society of North America. Sopha, ofColumbia, MD, displayed works-in-progress developments in digitaldetector design and non-uniform attenuation correction.
Sopha claims that the specifications for its version of digitalmeet or exceed those of its competitors, including arch-rivalADAC Medical Systems. ADAC introduced its Epic line of digitaldetectors at the RSNA meeting (SCAN 12/14/94). Sopha describesits technology as an enhanced Anger method that was designed tobring cost-effective digital to its installed base. Sopha's versionof digital will complement that of Summit Nuclear, a manufacturerof digital gamma cameras with whom Sopha signed a merger agreementlast week (see story, page 1).
Sopha's digital detectors will retrofit to the vendor's entireline of gamma cameras. It employs five flash analog-to-digitalconverters, positioned after the photomultiplier tube stage anddesigned to capture the five parameters that govern scintillationevent location and energy. The converters sample continuouslyat a rate of 100 nanoseconds and use a patented deconvolutionsampling process that makes the digitized signals more discreteand easier to resolve. Digital linearity energy and uniformityare performed on a single application-specific integrated circuit(ASIC).
Going digital will boost the count rate on the vendor's gammacameras to 400,000 counts per second in the 20% energy window,according to Lonnie Mixon, director of sales support. Digitaldetectors also enable Sopha's cameras to image up to four isotopesat once. In addition, Sopha's digital detectors will be retrofittableto the vendor's cameras in the field, which is not possible withEpic. Sopha hopes to be delivering digital detectors in mid-1995with a list price of about $20,000 as an option on a new camera.
Sopha's simultaneous transmission-emission attenuation correctionprotocol is being developed for Sopha's flagship Sophycamera DSTas well as DST-XL, a whole-body adjustable-angle camera that madeits RSNA debut at this year's meeting (SCAN 11/23/94).
Sopha's attenuation correction design features scanning linesources mounted opposite each detector head when they are configuredin the 90º position. The line sources can be folded awayfrom the camera heads when not needed to preserve the camera'sopen-gantry design and allow access to the patient. Sopha hopesto begin shipping the product in mid-1995. Like ADAC, Sopha willbe able to offer digital detectors and attenuation correctionon its products.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.